These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37801017)

  • 1. Validation of an antigenic site targeted by monoclonal antibodies against Puumala virus.
    Plyusnin A; Kedari A; Rissanen I; Iheozor-Ejiofor RP; Lundkvist Å; Vapalahti O; Levanov L
    J Gen Virol; 2023 Oct; 104(10):. PubMed ID: 37801017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining of MAbs-neutralizing sites on the surface glycoproteins Gn and Gc of a hantavirus using vesicular stomatitis virus pseudotypes and site-directed mutagenesis.
    Levanov L; Iheozor-Ejiofor RP; Lundkvist Å; Vapalahti O; Plyusnin A
    J Gen Virol; 2019 Feb; 100(2):145-155. PubMed ID: 30624178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus.
    de Carvalho Nicacio C; Lundkvist A; Sjölander KB; Plyusnin A; Salonen EM; Björling E
    J Med Virol; 2000 Apr; 60(4):446-54. PubMed ID: 10686029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of binding of Puumala virus neutralization site resembling peptide with a second-generation phage library.
    Heiskanen T; Li XD; Hepojoki J; Gustafsson E; Lundkvist A; Vaheri A; Lankinen H
    Protein Eng; 2003 Jun; 16(6):443-50. PubMed ID: 12874378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein.
    Rissanen I; Stass R; Krumm SA; Seow J; Hulswit RJ; Paesen GC; Hepojoki J; Vapalahti O; Lundkvist Å; Reynard O; Volchkov V; Doores KJ; Huiskonen JT; Bowden TA
    Elife; 2020 Dec; 9():. PubMed ID: 33349334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
    Mittler E; Wec AZ; Tynell J; Guardado-Calvo P; Wigren-Byström J; Polanco LC; O'Brien CM; Slough MM; Abelson DM; Serris A; Sakharkar M; Pehau-Arnaudet G; Bakken RR; Geoghegan JC; Jangra RK; Keller M; Zeitlin L; Vapalahti O; Ulrich RG; Bornholdt ZA; Ahlm C; Rey FA; Dye JM; Bradfute SB; Strandin T; Herbert AS; Forsell MNE; Walker LM; Chandran K
    Sci Transl Med; 2022 Mar; 14(636):eabl5399. PubMed ID: 35294259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of new Puumala orthohantavirus strains from Germany.
    Binder F; Reiche S; Roman-Sosa G; Saathoff M; Ryll R; Trimpert J; Kunec D; Höper D; Ulrich RG
    Virus Genes; 2020 Aug; 56(4):448-460. PubMed ID: 32328924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
    Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein.
    Hepojoki J; Strandin T; Wang H; Vapalahti O; Vaheri A; Lankinen H
    J Gen Virol; 2010 Sep; 91(Pt 9):2341-50. PubMed ID: 20444994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.
    Zvirbliene A; Kucinskaite-Kodze I; Razanskiene A; Petraityte-Burneikiene R; Klempa B; Ulrich RG; Gedvilaite A
    Viruses; 2014 Feb; 6(2):640-60. PubMed ID: 24513568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus-free rescue of fluorescent replication-defective vesicular stomatitis virus and pseudotyping with Puumala virus glycoproteins for use in neutralization tests.
    Paneth Iheozor-Ejiofor R; Levanov L; Hepojoki J; Strandin T; Lundkvist Å; Plyusnin A; Vapalahti O
    J Gen Virol; 2016 May; 97(5):1052-1059. PubMed ID: 26916544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization.
    Lundkvist A; Niklasson B
    Arch Virol; 1992; 126(1-4):93-105. PubMed ID: 1381914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Transitions of the Conserved and Metastable Hantaviral Glycoprotein Envelope.
    Rissanen I; Stass R; Zeltina A; Li S; Hepojoki J; Harlos K; Gilbert RJC; Huiskonen JT; Bowden TA
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Hantaviruses Harbored by Murid Rodents in Northwestern Ukraine and Discovery of a Novel Puumala Virus Strain.
    Williams EP; Taylor MK; Demchyshyna I; Nebogatkin I; Nesterova O; Khuda I; Chernenko L; Hluzd OA; Kutseva VV; Glass GE; Yanko N; Jonsson CB
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different cross-reactivity of human and rodent sera to Tula virus and Puumala virus.
    Tegshduuren E; Yoshimatsu K; Taruishi M; Endo R; Shimizu K; Koma T; Yasuda SP; Kariwa H; Arikawa J; Ishihara C
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e67-73. PubMed ID: 20116854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin A responses to Puumala hantavirus.
    de Carvalho Nicacio C; Björling E; Lundkvist A
    J Gen Virol; 2000 Jun; 81(Pt 6):1453-61. PubMed ID: 10811929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genomic characterisation of a fatal Puumala orthohantavirus case with low levels of neutralising antibodies.
    Tuiskunen Bäck A; Rasmuson J; Thunberg T; Rankin G; Wigren Byström J; Andersson C; Sjödin A; Forsell M; Ahlm C
    Infect Dis (Lond); 2022 Oct; 54(10):766-772. PubMed ID: 35713235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.
    Liang W; Zhou G; Liu W; Yang B; Li C; Wang H; Yang D; Ma W; Yu L
    Arch Virol; 2016 Oct; 161(10):2705-16. PubMed ID: 27422396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.